Epidemiology

David Gritz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Uveitis has been said to cause between 2.8 and 10% of blindness in the USA and cause approximately 30,000 new cases of blindness per year. Even if uveitis does not result in blindness, it can cause visual loss and multiple other ocular complications. In the Northern California Epidemiology of Uveitis Study, 31.9% of the patient cohort was affected by one or more complications over the 12-month study period (Gritz DC and Wong IG, The Northern California Epidemiology of Uveitis Study, previously unpublished data.). Thus, uveitis represents an important group of sight-threatening conditions. Uveitis is not only responsible for significant loss of vision and ocular morbidity, but also results in great medical economic costs and personal impact on patients in the form of financial and psychological stress (Gritz DC and Wong IG, unpublished data). Despite the facts, there is a paucity of evidence-based data on the epidemiologic, socioeconomic, and therapeutic aspects of this disease. Thankfully, the number of publications in this area seems to be expanding.

Original languageEnglish (US)
Title of host publicationIntraocular Inflammation
PublisherSpringer Berlin Heidelberg
Pages83-92
Number of pages10
ISBN (Electronic)9783540753872
ISBN (Print)9783540753858
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Uveitis
Epidemiology
Blindness
Medical Economics
Psychological Stress
Publications
Morbidity
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gritz, D. (2016). Epidemiology. In Intraocular Inflammation (pp. 83-92). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_4

Epidemiology. / Gritz, David.

Intraocular Inflammation. Springer Berlin Heidelberg, 2016. p. 83-92.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gritz, D 2016, Epidemiology. in Intraocular Inflammation. Springer Berlin Heidelberg, pp. 83-92. https://doi.org/10.1007/978-3-540-75387-2_4
Gritz D. Epidemiology. In Intraocular Inflammation. Springer Berlin Heidelberg. 2016. p. 83-92 https://doi.org/10.1007/978-3-540-75387-2_4
Gritz, David. / Epidemiology. Intraocular Inflammation. Springer Berlin Heidelberg, 2016. pp. 83-92
@inbook{2a0e4f691de742e68b00bb10e914c4e9,
title = "Epidemiology",
abstract = "Uveitis has been said to cause between 2.8 and 10{\%} of blindness in the USA and cause approximately 30,000 new cases of blindness per year. Even if uveitis does not result in blindness, it can cause visual loss and multiple other ocular complications. In the Northern California Epidemiology of Uveitis Study, 31.9{\%} of the patient cohort was affected by one or more complications over the 12-month study period (Gritz DC and Wong IG, The Northern California Epidemiology of Uveitis Study, previously unpublished data.). Thus, uveitis represents an important group of sight-threatening conditions. Uveitis is not only responsible for significant loss of vision and ocular morbidity, but also results in great medical economic costs and personal impact on patients in the form of financial and psychological stress (Gritz DC and Wong IG, unpublished data). Despite the facts, there is a paucity of evidence-based data on the epidemiologic, socioeconomic, and therapeutic aspects of this disease. Thankfully, the number of publications in this area seems to be expanding.",
author = "David Gritz",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-540-75387-2_4",
language = "English (US)",
isbn = "9783540753858",
pages = "83--92",
booktitle = "Intraocular Inflammation",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Epidemiology

AU - Gritz, David

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Uveitis has been said to cause between 2.8 and 10% of blindness in the USA and cause approximately 30,000 new cases of blindness per year. Even if uveitis does not result in blindness, it can cause visual loss and multiple other ocular complications. In the Northern California Epidemiology of Uveitis Study, 31.9% of the patient cohort was affected by one or more complications over the 12-month study period (Gritz DC and Wong IG, The Northern California Epidemiology of Uveitis Study, previously unpublished data.). Thus, uveitis represents an important group of sight-threatening conditions. Uveitis is not only responsible for significant loss of vision and ocular morbidity, but also results in great medical economic costs and personal impact on patients in the form of financial and psychological stress (Gritz DC and Wong IG, unpublished data). Despite the facts, there is a paucity of evidence-based data on the epidemiologic, socioeconomic, and therapeutic aspects of this disease. Thankfully, the number of publications in this area seems to be expanding.

AB - Uveitis has been said to cause between 2.8 and 10% of blindness in the USA and cause approximately 30,000 new cases of blindness per year. Even if uveitis does not result in blindness, it can cause visual loss and multiple other ocular complications. In the Northern California Epidemiology of Uveitis Study, 31.9% of the patient cohort was affected by one or more complications over the 12-month study period (Gritz DC and Wong IG, The Northern California Epidemiology of Uveitis Study, previously unpublished data.). Thus, uveitis represents an important group of sight-threatening conditions. Uveitis is not only responsible for significant loss of vision and ocular morbidity, but also results in great medical economic costs and personal impact on patients in the form of financial and psychological stress (Gritz DC and Wong IG, unpublished data). Despite the facts, there is a paucity of evidence-based data on the epidemiologic, socioeconomic, and therapeutic aspects of this disease. Thankfully, the number of publications in this area seems to be expanding.

UR - http://www.scopus.com/inward/record.url?scp=84958865369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958865369&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-75387-2_4

DO - 10.1007/978-3-540-75387-2_4

M3 - Chapter

AN - SCOPUS:84958865369

SN - 9783540753858

SP - 83

EP - 92

BT - Intraocular Inflammation

PB - Springer Berlin Heidelberg

ER -